Tenofovir Teva

/ Teva

Treatment of HIV or chronic hepatitis B: 1 tablet, once daily taken with food.
Pediatrics: not recommended for use in children under 12 years of age.
Elderly: no data available for patients over 65 years of age.
Renal Impairment: mild: no change in dose; moderate: 245 mg (1 tablet) every 48 hours; severe: 245 mg (1 tablet) every 72-96 hours

For the treatment of:
1. HIV 1 infected adults and pediatric patients 12 years of age and older in combination with
other antiretroviral medicinal products for the treatment of HIV.
2. Chronic hepatitis B in adults with:
• Compensated liver disease, with evidence of active viral replication, persistently
elevated serum alanine aminotransferase (ALT) levels and histological evidence of active
inflammation and/or fibrosis.
• Decompensated liver disease.

Hypersensitivity to tenofovir, tenofovir disoproxil fumarate or to any of the excipients; Lactation.

Pediatrics: not recommended for use in children under 12 years of age.
Elderly: no data available for patients over 65 years of age.
Renal impairment: Mild: no change in dose; Moderate: 245 mg (1 tablet) every 48 hours; Severe: 245 mg (1 tablet) every 72-96 hours.

For full details refer to the manufacturer.